NO970252L - Mixture for nasal administration of a drug - Google Patents

Mixture for nasal administration of a drug

Info

Publication number: NO970252L
Authority: NO; Norway
Prior art keywords: drug; mixture; nasal administration; nasal; administration
Prior art date: 1994-07-26

Application number

NO970252A

Other languages

Norwegian (no)

Other versions

NO970252D0 (en

Inventor

Peter Watts

Lisbeth Illum

Original Assignee

Danbiosyst Uk Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-26

Filing date

1997-01-21

Publication date

1997-01-21

1997-01-21 Application filed by Danbiosyst Uk Ltd filed Critical Danbiosyst Uk Ltd

1997-01-21 Publication of NO970252L publication Critical patent/NO970252L/en

1997-01-21 Publication of NO970252D0 publication Critical patent/NO970252D0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Otolaryngology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Cell Biology (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)

NO970252A 1994-07-26 1997-01-21 Mixture for nasal administration of a drug NO970252D0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9414966A GB9414966D0 (en)	1994-07-26	1994-07-26	Pharmaceutical compositions for the nasal administration of antiviral agents
PCT/GB1995/001735 WO1996003142A1 (en)	1994-07-26	1995-07-24	Drug delivery composition for the nasal administration of antiviral agents

Publications (2)

Publication Number	Publication Date
NO970252L true NO970252L (en)	1997-01-21
NO970252D0 NO970252D0 (en)	1997-01-21

Family

ID=10758832

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO970252A NO970252D0 (en)	1994-07-26	1997-01-21	Mixture for nasal administration of a drug

Country Status (7)

Country	Link
EP (1)	EP0773791A1 (en)
JP (1)	JPH10506376A (en)
CA (1)	CA2195639A1 (en)
FI (1)	FI970331A0 (en)
GB (2)	GB9414966D0 (en)
NO (1)	NO970252D0 (en)
WO (1)	WO1996003142A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0362531B1 (en)	1988-09-01	1999-11-10	Bayer Corporation	A human rhinovirus receptor protein that inhibits virus infectivity
US5879712A (en) *	1995-06-07	1999-03-09	Sri International	Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
WO1997032596A1 (en) *	1996-03-06	1997-09-12	Boehringer Ingelheim Pharmaceuticals, Inc.	Intercellular adhesion molecule powder formulation
GB9700624D0 (en)	1997-01-14	1997-03-05	Danbiosyst Uk	Drug delivery composition
GB9707934D0 (en) *	1997-04-18	1997-06-04	Danbiosyst Uk	Improved delivery of drugs to mucosal surfaces
US6391452B1 (en)	1997-07-18	2002-05-21	Bayer Corporation	Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
EP0994700A4 (en) *	1997-07-18	2000-10-18	Bayer Ag	METHODS FOR REMOVING RESIDUAL SOLVENT FROM NASAL MEDICINAL COMPOSITIONS
JP2004500305A (en) *	1997-10-31	2004-01-08	フアルマシア・コーポレーシヨン	Sustained-release composition containing gellan gum gel
ES2249846T3 (en) *	1997-12-02	2006-04-01	Archimedes Development Limited	COMPOSITIONS FOR NASAL ADMINISTRATION.
GB0015682D0 (en) *	2000-06-28	2000-08-16	Bristol Myers Squibb Co	Sprayable wound care composition
GB2378383A (en) *	2001-06-06	2003-02-12	Gursharan Moonga	Nasal delivery of pharmaceutical compositions in powder form
GB0300531D0 (en)	2003-01-10	2003-02-12	West Pharm Serv Drug Res Ltd	Pharmaceutical compositions
GB0328186D0 (en)	2003-12-05	2004-01-07	West Pharm Serv Drug Res Ltd	Intranasal compositions
GB0403938D0 (en) *	2004-02-21	2004-03-24	West Pharm Serv Drug Res Ltd	Chitosan containing solution
WO2008091588A1 (en)	2007-01-22	2008-07-31	Targacept, Inc.	Intranasal, buccal, and sublingual administration of metanicotine analogs
DE102008007759B4 (en)	2007-12-04	2009-09-24	Atlantichem Gmbh	Agent for preventing discoloration when washing textiles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4946870A (en) *	1986-06-06	1990-08-07	Union Carbide Chemicals And Plastics Company Inc.	Delivery systems for pharmaceutical or therapeutic actives
ATE114972T1 (en) *	1987-11-02	1994-12-15	Baylor College Medicine	USE OF ICAM-1 OR ITS FUNCTIONAL DERIVATIVES TO TREAT NON-SPECIFIC INFLAMMATION.
EP0362531B1 (en) *	1988-09-01	1999-11-10	Bayer Corporation	A human rhinovirus receptor protein that inhibits virus infectivity
SE8804164A0 (en) *	1988-11-17	1990-05-18	Per Prisell	Pharmaceutical preparation
GB2237510B (en) *	1989-11-04	1993-09-15	Danbiosyst Uk	Small particle drug compositions for nasal administration
AU2763692A (en) *	1991-10-02	1993-05-03	Boehringer Ingelheim Pharmaceuticals, Inc.	Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
HUT75827A (en) *	1992-06-22	1997-05-28	Bayer Ag	Multimeric forms of human rhinovirus receptor protein
GB9310412D0 (en) *	1993-05-20	1993-07-07	Danbiosyst Uk	Nasal nicotine system

1994
- 1994-07-26 GB GB9414966A patent/GB9414966D0/en active Pending
1995
- 1995-07-24 EP EP95925947A patent/EP0773791A1/en not_active Withdrawn
- 1995-07-24 JP JP8505576A patent/JPH10506376A/en active Pending
- 1995-07-24 CA CA002195639A patent/CA2195639A1/en not_active Abandoned
- 1995-07-24 GB GB9700817A patent/GB2305606B/en not_active Expired - Fee Related
- 1995-07-24 WO PCT/GB1995/001735 patent/WO1996003142A1/en not_active Application Discontinuation
1997
- 1997-01-21 NO NO970252A patent/NO970252D0/en not_active Application Discontinuation
- 1997-01-27 FI FI970331A patent/FI970331A0/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU707462B2 (en)	1999-07-08
GB2305606A (en)	1997-04-16
GB9414966D0 (en)	1994-09-14
FI970331L (en)	1997-01-27
JPH10506376A (en)	1998-06-23
EP0773791A1 (en)	1997-05-21
GB9700817D0 (en)	1997-03-05
AU2988695A (en)	1996-02-22
WO1996003142A1 (en)	1996-02-08
NO970252D0 (en)	1997-01-21
GB2305606B (en)	1998-08-05
CA2195639A1 (en)	1996-02-08
FI970331A0 (en)	1997-01-27

Publication	Publication Date	Title
NO975931D0 (en)	1997-12-17	Mixture for administration of drug
NO970252D0 (en)	1997-01-21	Mixture for nasal administration of a drug
NO20002851D0 (en)	2000-06-02	Compositions for nasal administration of drugs
HRP960300B1 (en)	2000-10-31	Inhaler for administration of blister-packed medicaments
NO20001219D0 (en)	2000-03-09	Mixture for drug administration
US5506203C1 (en)	2001-02-06	Systemic administration of a therapeutic preparation
GB2303064B (en)	1999-10-06	Medicament for nasal administration
KR950700754A (en)	1995-02-20	New drugs (NOVEL MEDICAMENT)
NO953549L (en)	1995-09-08	Infusion set for an intermittent or continuous delivery of a therapeutic substance
IS4566A (en)	1997-09-22	Medicinal product for intravenous administration
NO175515C (en)	1994-10-26	Process for the preparation of a pharmaceutical preparation for percutaneous delivery
NO972798D0 (en)	1997-06-17	Intravaginal drug delivery devices for administration of 17 <beta> -estradiol precursors
MX9101175A (en)	1992-05-04	PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION
NO950238D0 (en)	1995-01-23	Mixture for delivery of drug to the lymphatic system
NO173486C (en)	1993-12-22	Procedure for Preparing a Pharmaceutical Preparation for Transdermal Drug Administration
HUP9900751A3 (en)	2000-07-28	Stable pharmaceutical forms of administration containing parathormone
FI954007L (en)	1996-03-01	Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as a drug substance
NO177485C (en)	1995-09-27	Process for the preparation of a pharmaceutical inhalation preparation
NO179396C (en)	1996-10-02	Process for the preparation of a drug administration form for ruminants
NO981537L (en)	1998-04-03	Process for the preparation of antimalarial drugs
NO20000811D0 (en)	2000-02-18	Method of selecting a drug
FI944460A0 (en)	1994-09-27	Process for the preparation of a drug preparation
IT1223132B (en)	1990-09-12	PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION
FI950065A (en)	1995-03-02	A device for administering a medicament and a method of making such a device
EE9600050A (en)	1996-10-15	A process for the preparation of oral compositions containing quinolones and a tablet for the oral administration of quinolones

Legal Events

Date	Code	Title	Description
2006-02-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application